Previous studies have indicated that G6PD overexpression was associated with a poor prognosis in certain types of cancer, including AML, hepatocellular carcinoma, invasive breast carcinoma, and mesothelioma (36). The gene discussed is G6PD; the disease is acute myeloid leukemia.